Relmacabtagene Autoleucel in Hematologic Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Relmacabtagene Autoleucel in Hematologic Malignancies	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Not yet recruiting	Not stated	2023-11-21		NCT06142188

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Ming Ju Biotechnology Co., Ltd.	7

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing cancer hospital	Beijing	China	2
Peking University International Hospital	Beijing	China	1

Clinical trials